Insider Transactions by Patterson Matthew R

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJan 15, 2020Option Exercise$60.00261,45815,687,4800Jan 15, 2020, 01:35 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJan 15, 2020Option Exercise$60.00171,81410,308,8400Jan 15, 2020, 01:35 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJan 08, 2020Option Exercise$3.10162,538503,567261,458Jan 10, 2020, 06:18 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerDec 05, 2019Option Exercise$59.211,974116,881111,420Dec 09, 2019, 05:16 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerNov 08, 2019Option Exercise$19.7528,852569,827127,820Nov 12, 2019, 05:32 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerSep 05, 2019Option Exercise$31.021,97461,233113,394Sep 09, 2019, 04:05 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerAug 12, 2019Sale$21.7740,000870,835135,368Aug 14, 2019, 07:03 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJun 05, 2019Option Exercise$37.313,332124,317115,368Jun 07, 2019, 04:41 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerFeb 25, 2019Sale$15.5242,000652,020135,700Feb 27, 2019, 04:31 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerDec 06, 2018Option Exercise$0.7840,00031,20055,000Dec 10, 2018, 04:39 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerOct 01, 2018Sale$19.4742,000817,75223,078Oct 02, 2018, 07:04 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerSep 24, 2018Option Exercise$0.7815,00011,70015,000Sep 24, 2018, 06:12 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerSep 18, 2018Option Exercise$21.1025,904546,44512,952Sep 20, 2018, 07:01 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJul 02, 2018Option Exercise$19.5742,000821,90419,599Jul 05, 2018, 06:34 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJul 03, 2018Option Exercise$20.4253,8021,098,44326,901Jul 05, 2018, 06:34 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RChief Executive OfficerJul 05, 2018Option Exercise$20.4146,294944,90723,147Jul 05, 2018, 06:34 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOMay 21, 2018Sale$19.4740,600790,33213,600May 23, 2018, 06:13 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOApr 02, 2018Sale$15.401,40021,555700Apr 04, 2018, 09:01 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOOct 02, 2017Option Exercise$14.3520,000287,01710,000Oct 04, 2017, 08:25 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOOct 02, 2017Sale$27.9215,000418,853171,814Oct 04, 2017, 08:25 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOSep 18, 2017Option Exercise$12.9216,916218,6078,458Sep 19, 2017, 06:00 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOSep 15, 2017Option Exercise$12.893,08439,7541,542Sep 19, 2017, 06:00 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOJul 12, 2017Sale$20.002,85057,007198,964Jul 14, 2017, 08:01 PM
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPresident & CEOJul 13, 2017Sale$20.0012,150243,052186,814Jul 14, 2017, 08:01 PM